MedPath

COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE

COMIRNATY OMICRON XBB.1.5 (3 MICROGRAMOS/DOSIS) CONCENTRADO PARA DISPERSION INYECTABLE

Pending
Register Number

1201528024

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Sep 4, 2023

Dosage Form

CONCENTRADO PARA DISPERSION INYECTABLE

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201528024
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

RAXTOZINAMERANActive
Quantity: 0,015 mg/ml
Name: RAXTOZINAMERAN

ATC CLASSIFICATION (3)

J07B
J07BN
J07BN01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.